| 1 |
cyclic GMP-AMP synthase-stimulator of interferon genes
(10 times)
|
Immune System Diseases
(2 times)
|
DNA-PK (2 times)
APCs (1 time)
CBMN (1 time)
|
2017 Ester alkaloids from Cephalotaxus interfere with the 2'3'-cGAMP-induced type I interferon pathway in vitro.
|
| 2 |
cGAMP synthase-stimulator of IFN genes
(1 time)
|
Science
(1 time)
|
---
|
2020 Bacterial-induced cell fusion is a danger signal triggering cGAS-STING pathway via micronuclei formation.
|
| 3 |
cGAS-stimulator of interferon genes
(1 time)
|
Nanomedicine
(1 time)
|
cGAS (1 time)
ELISA (1 time)
HDAC3 (1 time)
|
2020 HDAC3 inhibition ameliorates ischemia/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway.
|
| 4 |
cyclic GMP-AMP synthase interferon genes
(1 time)
|
Neoplasms
(1 time)
|
RMC (1 time)
|
2020 Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.
|
| 5 |
cyclic GMP-AMP synthase-signaling effector stimulator of interferon genes
(1 time)
|
|
MN (1 time)
|
2020 Induction of Micronuclei in Cervical Cancer Treated with Radiotherapy.
|
| 6 |
cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes
(1 time)
|
|
ICI (1 time)
|
2020 Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy.
|
A Search Service for Abbreviation / Long Form